mRNA transfection-based, feeder-free, induced pluripotent stem cells derived from adipose tissue of a 50-year-old patient (Q39173476)

9 September 2017

title

mRNA transfection-based, feeder-free, induced pluripotent stem cells derived from adipose tissue of a 50-year-old patient (English)

1 reference

9 September 2017

1 reference

Martin Fussenegger

1 reference

9 September 2017

Henryk Zulewski

1 reference

9 September 2017

Boon Chin Heng

1 reference

9 September 2017

Karl Heinimann

1 reference

9 September 2017

Peter Miny

1 reference

9 September 2017

Giandomenica Iezzi

1 reference

9 September 2017

Katharina Glatz

1 reference

9 September 2017

Arnaud Scherberich

1 reference

9 September 2017

publication date

28 March 2013

1 reference

9 September 2017

published in

Metabolic Engineering

1 reference

9 September 2017

1 reference

9 September 2017

page(s)

9-24

1 reference

Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Adaptation to culture of human embryonic stem cells and oncogenesis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Senescence impairs successful reprogramming to pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Xeno-free culture of human pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Role of Cripto-1 in stem cell maintenance and malignant progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Recombinant vitronectin is a functionally defined substrate that supports human embryonic stem cell self-renewal via alphavbeta5 integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Adipose-derived stem cells: isolation, expansion and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Current regulatory issues in cell and tissue therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Genetics and genomics of core short tandem repeat loci used in human identity testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

High-throughput discovery of synthetic surfaces that support proliferation of pluripotent cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: its benefits in hESC expansion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Somatic coding mutations in human induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Recent Progress on Chemical Biology of Pluripotent Stem Cell Self-renewal, Reprogramming and Cardiomyogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Expansion and differentiation of germline-derived pluripotent stem cells on biomaterials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Copy number variation and selection during reprogramming to pluripotency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

The expansion of human ES and iPS cells on porous membranes and proliferating human adipose-derived feeder cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

A synthetic, xeno-free peptide surface for expansion and directed differentiation of human induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Linking the p53 tumour suppressor pathway to somatic cell reprogramming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Identification of developmental pluripotency associated 5 expression in human pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

A defined glycosaminoglycan-binding substratum for human pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Synthetic surfaces for human embryonic stem cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Basic fibroblast growth factor support of human embryonic stem cell self-renewal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

The Ink4/Arf locus is a barrier for iPS cell reprogramming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Characterization of adipose tissue-derived cells isolated with the Celution system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

A chemical platform for improved induction of human iPSCs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Robust activation of the human but not mouse telomerase gene during the induction of pluripotency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Protocols for cytogenetic studies of human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Concise review: The magic act of generating induced pluripotent stem cells: many rabbits in the hat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Long-term microcarrier suspension cultures of human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

A comparative study of induced pluripotent stem cells generated from frozen, stocked bone marrow- and adipose tissue-derived mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Long term culture of human embryonic stem cells on recombinant vitronectin in ascorbate free media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Embryonic stem cell trials for macular degeneration: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

New approaches for the generation of induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Immortalization eliminates a roadblock during cellular reprogramming into iPS cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Laminin isoforms in human embryonic stem cells: synthesis, receptor usage and growth support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Feeder-free derivation of human induced pluripotent stem cells with messenger RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

A ROCK inhibitor permits survival of dissociated human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Modeling familial Alzheimer's disease with induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

Generation of induced pluripotent stem cells using recombinant proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMBEN.2013.02.004

10.1016/J.YMBEN.2013.02.004

7 January 2021

Identifiers

DOI

1 reference

9 September 2017

1 reference